Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
- PMID: 31377881
- PMCID: PMC7339114
- DOI: 10.1007/s11934-019-0917-1
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
Abstract
Purpose of review: The purpose of this review is to summarize the role and significance of inflammation as a putative additional factor contributing to lower urinary tract symptoms and the progression of benign prostatic hyperplasia. We review (1) the histologic definition of prostatic inflammation and its prevalence, (2) the effects inflammation in the prostate including on risk of acute urinary retention, and (3) the effects of systemic inflammation on the prostate and on voiding.
Recent findings: Inflammation is a highly prevalent finding in the prostate, both on a histological and biochemical level. Men with inflammation have higher IPSS scores and increased prostate size; however, these differences appear to be imperceptibly small. Men with inflammation do experience a significantly increased risk of developing acute urinary retention, an event that is associated with significant morbidity. Recently, attempts have been made to identify more specific biochemical markers of local inflammation, and to identify regional patterns of inflamed tissue within the prostate which may be associated with higher IPSS scores, accelerated progression, and AUR. The effects of systemic inflammatory states, most notably MetS, and their role in LUTS have also been examined. Inflammation is a common finding in prostates of aging men, but its contribution to lower urinary tract symptoms and benign prostatic hyperplasia progression appears to be small when considered as a clinically relevant entity. Advances in the understanding of different forms of inflammation, and their impact when experienced in different locations within the prostate, may refine this knowledge. Systemic inflammation affects voiding, including in the absence of a prostate, but again significant effects of systemic inflammation on the prostate itself are also difficult to demonstrate. Prostatic inflammation is associated with a significantly increased risk of acute urinary retention.
Keywords: Benign prostate hyperplasia; Inflammation; Lower urinary tract symptoms; Prostatic inflammation.
Similar articles
-
Inflammation, Voiding and Benign Prostatic Hyperplasia Progression.J Urol. 2019 May;201(5):868-870. doi: 10.1097/JU.0000000000000049. J Urol. 2019. PMID: 30694937 Free PMC article. No abstract available.
-
Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.Prostate. 2018 Jul;78(10):743-752. doi: 10.1002/pros.23518. Epub 2018 Apr 2. Prostate. 2018. PMID: 29608020
-
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1. J Urol. 2016. PMID: 27378134 Clinical Trial.
-
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).BJU Int. 2013 Aug;112(4):432-41. doi: 10.1111/bju.12118. Epub 2013 Apr 12. BJU Int. 2013. PMID: 23650937 Review.
-
Correlation between benign prostatic hyperplasia and inflammation.Curr Opin Urol. 2013 Jan;23(1):5-10. doi: 10.1097/MOU.0b013e32835abd4a. Curr Opin Urol. 2013. PMID: 23159991 Review.
Cited by
-
TGFβ2 mediates oxidative stress-induced epithelial-to-mesenchymal transition of bladder smooth muscle.In Vitro Cell Dev Biol Anim. 2024 Feb 26. doi: 10.1007/s11626-024-00864-9. Online ahead of print. In Vitro Cell Dev Biol Anim. 2024. PMID: 38409639
-
Evaluating the Impact of Benign Prostatic Hyperplasia Surgical Treatments on Sexual Health.Biomedicines. 2024 Jan 5;12(1):110. doi: 10.3390/biomedicines12010110. Biomedicines. 2024. PMID: 38255215 Free PMC article. Review.
-
Increased Risk of Benign Prostate Hyperplasia (BPH) in Patients with Gout: A Longitudinal Follow-Up Study Using a National Health Screening Cohort.Diagnostics (Basel). 2023 Dec 26;14(1):55. doi: 10.3390/diagnostics14010055. Diagnostics (Basel). 2023. PMID: 38201364 Free PMC article.
-
The emerging role of the urinary microbiome in benign noninfectious urological conditions: an up-to-date systematic review.World J Urol. 2023 Nov;41(11):2933-2948. doi: 10.1007/s00345-023-04588-5. Epub 2023 Sep 22. World J Urol. 2023. PMID: 37737900 Review.
-
Selenium in combination with a tomato lipid extract as a therapy for benign prostatic hyperplasia and its alterations in rats with induced BPH.J Cell Mol Med. 2023 Oct;27(20):3147-3156. doi: 10.1111/jcmm.17903. Epub 2023 Sep 19. J Cell Mol Med. 2023. PMID: 37726932 Free PMC article.
References
-
- Asplund R Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84:297–301. - PubMed
-
- Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol. 1995;154:1764–9. - PubMed
-
- Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 1995;153:1510–5. - PubMed
-
- Teng J, Zhang D, Li Y, Yin L, Wang K, Cui X, et al. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int. 2013;111:312–23. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials